NCT02742350

Brief Summary

Heart surgery procedures are still widely used worldwide for the treatment of patients with heart problems, and rates of complications in the postoperative period related to them remain high. In these patients, physical conditioning programs result in improved functional capacity, and reducing the heart rate and systolic blood pressure. The inspiratory muscle training is also emerging as a valuable strategy in the treatment of cardiac patients. The study of the interaction between cardiac rehabilitation and high intensity IMT about these changes is not yet understood in this population. The aim of this study is to assess the effects of inspiratory muscle training high intensity associated with cardiac rehabilitation exercise performance of patients in the postoperative period of CABG surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Sep 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 10, 2015

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 19, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2016

Completed
Last Updated

April 28, 2017

Status Verified

April 1, 2017

Enrollment Period

1.1 years

First QC Date

March 7, 2016

Last Update Submit

April 27, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Six-minute walk test

    The patient is set to walk in a corridor of 30 meters delimited cones for six minutes in order to go as far as possible. Every minute the patient is stimulated by the evaluator.

    1 week, up to 4 week, up to 8 week, through study completion, an average of 12 week

Secondary Outcomes (3)

  • 30-s chair-stand

    1 week, up to 4 week, up to 8 week, through study completion, an average of 12 week

  • respiratory muscle strength test

    1 week, up to 4 week, up to 8 week, through study completion, an average of 12 week

  • Quality of life

    1 week, through study completion, an average of 12 week

Study Arms (2)

IMT+Exercise

EXPERIMENTAL

The inspiratory muscle training protocol (IMT) high intensity is achieved with a device with linear load pressure (POWERbreathe Plus Light Resistance®, SP, BR) that allows loads up to -90cmH2O. IMT is performed for 36 sessions (12 weeks) with weekly frequency of three times a week under supervision prior to the cardiac rehabilitation. The training protocol consists of five series with 10 repetitions each set until the 8th week with increase in the number of sets of repetitions of the 8th to 12th week, with two minutes or according to patient feedback using the modified Borg scale . Aerobic training lasts 40 minutes (5 minutes heating 30 minute workout and 5 minutes desaqueciemento. During training vital signs such as heart rate, blood pressure (BP) and peripheral oxygen saturation (SpO2) are evaluated and the feeling of effort the patient should not exceed the level of 8 according to the modified Borg scale.

Device: IMT - POWERbreathe Plus Light Resistance®, SP, BR

Exercise Control

NO INTERVENTION

Aerobic Exercise and Stretching

Interventions

POWERbreathe Plus Light Resistance®, SP, BR

IMT+Exercise

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients in the postoperative period of elective CABG
  • Between the fourteenth and the thirtieth day after surgery
  • Between 30 and 70 years old

You may not qualify if:

  • Decompensated heart failure
  • Unstable angina
  • Moderate respiratory disease severe
  • Active infectious disease or fever
  • Disabling peripheral vascular disease
  • Unstable ventricular arrhythmias
  • Use of cardiac pacemaker.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rodrigo Della Méa Plentz

Porto Alegre, Rio Grande do Sul, 90130051, Brazil

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

March 7, 2016

First Posted

April 19, 2016

Study Start

September 10, 2015

Primary Completion

September 30, 2016

Study Completion

December 30, 2016

Last Updated

April 28, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations